Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor

Adrien Bernard, Jacqueline Gao-Li, Cláudio A. Franco, Tahar Bouceba, Alexis Huet, Zhenlin Li

Journal of Biological Chemistry · 2009 · 165 citations · 60 references

DOIFull text

Open access

Concepts

Abstract

Pigment epithelium-derived factor (PEDF) is a multifunctional protein with neurotrophic, anti-oxidative, and anti-inflammatory properties. It is also one of the most potent endogenous inhibitors of angiogenesis, playing an important role in restricting tumor growth, invasion, and metastasis. Studies show that PEDF binds to cell surface proteins, but little is known about how it exerts its effects. Recently, research identified phospholipase A2/nutrin/patatin-like phospholipase domain-containing 2 as one PEDF receptor. To identify other receptors, we performed yeast two-hybrid screening using PEDF as bait and discovered that the non-integrin 37/67-kDa laminin receptor (LR) is another PEDF receptor. Co-immunoprecipitation, His tag pulldown, and surface plasmon resonance assays confirmed the interaction between PEDF and LR. Using the yeast two-hybrid method, we further restricted the LR-interacting domain on PEDF to a 34-amino acid (aa) peptide (aa 44–77) and the PEDF-interacting domain on LR to a 91-aa fragment (aa 120–210). A 25-mer peptide named P46 (aa 46–70), derived from 34-mer, interacts with LR in surface plasmon resonance assays and binds to endothelial cell (EC) membranes. This peptide induces EC apoptosis and inhibits EC migration, tube-like network formation in vitro, and retinal angiogenesis ex vivo, like PEDF. Our results suggest that LR is a real PEDF receptor that mediates PEDF angiogenesis inhibition. Pigment epithelium-derived factor (PEDF) is a multifunctional protein with neurotrophic, anti-oxidative, and anti-inflammatory properties. It is also one of the most potent endogenous inhibitors of angiogenesis, playing an important role in restricting tumor growth, invasion, and metastasis. Studies show that PEDF binds to cell surface proteins, but little is known about how it exerts its effects. Recently, research identified phospholipase A2/nutrin/patatin-like phospholipase domain-containing 2 as one PEDF receptor. To identify other receptors, we performed yeast two-hybrid screening using PEDF as bait and discovered that the non-integrin 37/67-kDa laminin receptor (LR) is another PEDF receptor. Co-immunoprecipitation, His tag pulldown, and surface plasmon resonance assays confirmed the interaction between PEDF and LR. Using the yeast two-hybrid method, we further restricted the LR-interacting domain on PEDF to a 34-amino acid (aa) peptide (aa 44–77) and the PEDF-interacting domain on LR to a 91-aa fragment (aa 120–210). A 25-mer peptide named P46 (aa 46–70), derived from 34-mer, interacts with LR in surface plasmon resonance assays and binds to endothelial cell (EC) membranes. This peptide induces EC apoptosis and inhibits EC migration, tube-like network formation in vitro, and retinal angiogenesis ex vivo, like PEDF. Our results suggest that LR is a real PEDF receptor that mediates PEDF angiogenesis inhibition. Pigmented epithelium-derived factor (PEDF), 2The abbreviations used are: PEDF, pigment epithelium-derived factor; AD, activation domain; BD, binding domain; KAP, keratin-associated protein; LR laminin receptor; PNPLA2, PLA2/nutrin/patatin-like phospholipase domain-containing 2; RU, resonance unit; TUNEL, terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick end labeling; Y2H, yeast two-hybrid; aa, amino acid(s); HuBMEC, human bone marrow endothelial cell; VEGF, vascular endothelial growth factor; bFGF, basic fibroblast growth factor; MAPK, mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase; FBS, fetal bovine serum; Ni-NTA, nickel-nitrilotriacetic acid; PBS, phosphate-buffered saline; DAPI, 4′,6′-diamino-2-phenylindole; SPR, surface plasmon resonance; siRNA, small interfering RNA; HA, hemagglutinin; EC, endothelial cell; X-α-Gal, 5′-bromo-4-chloro-3′-indolyl-α-d-galactopyranoside. also known as SERPIN F1 and EPC1, is a 50-kDa serpin-like peptide. Although first identified in cultured pigment epithelial cells from fetal human retinas (1Tombran-Tink J. Chader G.G. Johnson L.V. Exp. Eye Res... 1991; 53: 411-414Google Scholar), we now know that liver, kidney, heart, testis, and lung tissues also express PEDF (2Tombran-Tink J. Mazuruk K. Rodriguez I.R. Chung D. Linker T. Englander E. Chader G.J. Mol. Vis... 1996; 2: 11Google Scholar). PEDF influences many biological processes. It is anti-angiogenic, anti-tumorigenic, anti-inflammatory, anti-oxidative, neurotrophic, and neuroprotective, and it exhibits anti-vasopermeability properties (3Bouck N. Trends Mol. Med... 2002; 8: 330-334Google Scholar, 4Tombran-Tink J. Barnstable C.J. Nat. Rev. Neurosci... 2003; 4: 628-636Google Scholar, 5Becerra S.P. Exp. Eye Res... 2006; 82: 739-740Google Scholar, 6Ek E.T. Dass C.R. Choong P.F. Trends Mol. Med... 2006; 12: 497-502Google Scholar, 7Zhang S.X. Wang J.J. Gao G. Shao C. Mott R. Ma J.X. FASEB J... 2006; 20: 323-325Google Scholar, 8Yamagishi S. Nakamura K. Ueda S. Kato S. Imaizumi T. Cell Tissue Res... 2005; 320: 437-445Google Scholar-9Liu H. Ren J.G. Cooper W.L. Hawkins C.E. Cowan M.R. Tong P.Y. Proc. Natl. Acad. Sci. U. S. A... 2004; 101: 6605-6610Google Scholar). These diverse actions affect many cell types, including retinal cells (10Yamagishi S. Inagaki Y. Amano S. Okamoto T. Takeuchi M. Makita Z. Biochem. Biophys. Res. Commun... 2002; 296: 877-882Google Scholar), neuronal cells (11Steele F.R. Chader G.J. Johnson L.V. Tombran-Tink J. Proc. Natl. Acad. Sci. U. S. A... 1993; 90: 1526-1530Google Scholar), endothelial cells (12Stellmach V. Crawford S.E. Zhou W. Bouck N. Proc. Natl. Acad. Sci. U. S. A... 2001; 98: 2593-2597Google Scholar), and hematopoietic stem cells (13Selleri C. Ragno P. Ricci P. Visconte V. Scarpato N. Carriero M.V. Rotoli B. Rossi G. Montuori N. Blood.. 2006; 108: 2476-2484Google Scholar). X-ray diffraction studies show that PEDF has an asymmetrical charge distribution (14Simonovic M. Gettins P.G. Volz K. Proc. Natl. Acad. Sci. U. S. A... 2001; 98: 11131-11135Google Scholar). A high density of basic residues on one side of the molecule (positive) interact with heparin and glycosaminoglycans, whereas acidic residues on the opposite side (negative) interact with type-1 collagen (15Alberdi E. Hyde C.C. Becerra S.P. Biochemistry.. 1998; 37: 10643-10652Google Scholar, 16Yasui N. Mori T. Morito D. Matsushita O. Kourai H. Nagata K. Koide T. Biochemistry.. 2003; 42: 3160-3167Google Scholar, 17Becerra S.P. Perez-Mediavilla L.A. Weldon J.E. Locatelli-Hoops S. deS Senanayake P. Notari L. Notario V. Hollyfield J.G. J. Biol. Chem... 2008; 283: 33310-33320Google Scholar, 18Meyer C. Notari L. Becerra S.P. J. Biol. Chem... 2002; 277: 45400-45407Google Scholar-19Hosomichi J. Yasui N. Koide T. Soma K. Morita I. Biochem. Biophys. Res. Commun... 2005; 335: 756-761Google Scholar). Yet the mechanisms explaining the diverse biological activities of PEDF remain unclear. A ligand/receptor interaction at the cell membrane seemed likely, in addition to interactions within extracellular matrices, because of the diverse effects and ubiquitous expression of PEDF and the fact that most PEDF deposits remain within extracellular matrices (20Alberdi E.M. Weldon J.E. Becerra S.P. BMC Biochem... 2003; 4: 1Google Scholar). We suspected that distinct PEDF receptors elicit divergent signals to cause different biological effects. Indeed, evidence shows that PEDF binds at least two receptors: a 60-kDa receptor in ECs and an 80-kDa receptor in neuronal cells (21Alberdi E. Aymerich M.S. Becerra S.P. J. Biol. Chem... 1999; 274: 31605-31612Google Scholar, 22Bilak M.M. Becerra S.P. Vincent A.M. Moss B.H. Aymerich M.S. Kuncl R.W. J. Neurosci... 2002; 22: 9378-9386Google Scholar, 23Aymerich M.S. Alberdi E.M. Martínez A. Becerra S.P. Investig. Ophthalmol. Vis. Sci... 2001; 42: 3287-3293Google Scholar-24Yamagishi S. Inagaki Y. Nakamura K. R. T. A. Imaizumi T. J. Mol. Cell 2004; 37: Scholar). has identified two on a peptide 44–77) and a peptide S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar). peptide interacts with the 80-kDa receptor identified on cells and (21Alberdi E. Aymerich M.S. Becerra S.P. J. Biol. Chem... 1999; 274: 31605-31612Google Scholar, 22Bilak M.M. Becerra S.P. Vincent A.M. Moss B.H. Aymerich M.S. Kuncl R.W. J. Neurosci... 2002; 22: 9378-9386Google Scholar), and retinal M.S. Alberdi E.M. Martínez A. Becerra S.P. Investig. Ophthalmol. Vis. Sci... 2001; 42: 3287-3293Google to the and anti-vasopermeability properties of PEDF H. Ren J.G. Cooper W.L. Hawkins C.E. Cowan M.R. Tong P.Y. Proc. Natl. Acad. Sci. U. S. A... 2004; 101: 6605-6610Google Scholar, S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar). Becerra and L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; identified 80-kDa PLA2/nutrin/patatin-like phospholipase domain-containing 2 as a PEDF receptor that binds the S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; in that the in cell tumor density and peptide induces endothelial cell migration, and inhibits angiogenesis, a distinct EC receptor. We know the of the 60-kDa receptor. PEDF is one of the most potent endogenous inhibitors of angiogenesis, the of the vascular network from It inhibits endothelial cell in the of as vascular endothelial growth factor and fibroblast growth factor I. M. E. Mori K. M. L. K. K. S. Tong P. P. J. Investig. Ophthalmol. Vis. Sci... 2002; Scholar, H. M. Tombran-Tink J. J. Biochem. Biophys. Res. Commun... 2002; S. Y. Nakamura T. Y. T. H. J. Cell Sci... 2005; Scholar). show density in as the and that PEDF a role as a angiogenesis Bouck C. M.R. J. Crawford S.E. Nat. Med... 2003; Scholar). PEDF is It growth and It that the effects of PEDF endothelial cell the activation of the T. Zhou W. M. Bouck Nat. Med... 2002; 8: Scholar). and endothelial cell apoptosis in the of PEDF R. S. T. J. Exp. Med... 2004; Scholar, L. Barnstable C.J. Tombran-Tink J. Biochem. Biophys. Res. Commun... 2006; Scholar). Recently, J. M. J. Biol. Chem... 2006; that PEDF inhibits angiogenesis in retinal PEDF of the of This to receptors PEDF and to how We used a yeast two-hybrid to identify PEDF to that PEDF Our results that the non-integrin 37/67-kDa laminin receptor (LR) is a PEDF receptor. LR the 60-kDa receptor identified in ECs S. Inagaki Y. Nakamura K. R. T. A. Imaizumi T. J. Mol. Cell 2004; 37: Scholar). LR is a laminin receptor. It also mediates protein J. J. C. and S. J. and as a receptor as and S. J. Scholar, C. J. 2004; B. D. K. H. J. 2006; Scholar). LR is in and including cell growth, migration, and J. G. E. C. D. 2008; Scholar). Our research shows that LR PEDF We identified a 25-mer LR-interacting domain on PEDF and a PEDF-interacting domain on LR. 25-mer peptide exerts the and effects on ECs as PEDF. of PEDF used a two-hybrid of to a human with to the activation domain of the factor in a We used PEDF in a with the domain at We performed interaction on high in the to the We the in and with the using the to and PEDF different human PEDF amino and and the and of the we LR amino and with and and We the We the interaction between different of PEDF and LR the S. as performed as W.L. Moss J. M. J. Biol. Chem... with and protein as T. 2: and with and in Cell bone marrow endothelial cells P. C. D. A.M. M.M. in endothelial cell 2 We cultured cells in with at in a of We cells in with with and and Cell PEDF (aa and LR (aa in and to and expression We two cells that we at the using to the PEDF in and in used the and to human PEDF We fragment the and of the and LR and used to human LR We the and of the We PEDF from cells and laminin receptor from with to the cells with and we with and in We cells with We the cells with bovine with and and tag Cell in bovine We cells with and with in the We the cells in with We cells with a of the PEDF-interacting domain using We the a domain with the of a and a an interaction between the peptide and protein a with LR. 25-mer P46 (aa and We also peptide protein a we the interaction in real between PEDF peptide P46 and (aa (aa from E. and on a to a of between and resonance to the We a the To we also used PEDF protein and peptide P46 on with and binding We used PEDF protein and peptide P46 to We results with to to a with peptide at To the binding we used peptide at in the binding the first with LR LR at the at to with at We cells with and with with DAPI, and We with a We used a 25-mer peptide derived from keratin-associated protein S. N. E. A. C. A. J. Investig. 2008; as a peptide. using and a of inhibitors We protein using We of protein with and with We the to the We the with at We the at with the and in with a with We used to with with the protein at with 2 of on a We protein and the we the at We the a of We the with PBS, the We performed with as His PEDF binding to LR His tag of with as Notari L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; Scholar). PEDF protein with of (aa of (aa extracellular from E. in binding and at with We the in binding to the and at 2 with the and we with binding We the with of and with performed as M. A. G. J. D. E. Z. 2008; Scholar). in with of growth at We cultured cells in with FBS, and We the effects of PEDF, 25-mer peptide peptide on tube-like We from and the endothelial We performed distinct angiogenesis as C.C. E. J. Investig. Ophthalmol. Vis. Sci... 1996; 37: Scholar). PEDF, peptide P46 the of We used about of bFGF, of PEDF, and of to We used an to the of the and and the performed terminal deoxynucleotidyl transferase-mediated biotin-dUTP nick end using an Cell We at in in the cells in growth We cells with PEDF P46 in the of and We cells with with and to the We cell with We the of cells We the at and We a using a We cells with and in with and We the and LR in at We used to the human LR in and We used as a of the the and we used in We cells with to the We with We using in a We the using and the S.E. We to and with of 37/67-kDa LR as a PEDF the the expression and distinct biological of PEDF, we that peptide a of To we a screening a human using PEDF (aa as We the on high We and from the that with We the from with the that of membrane PEDF receptors, as and 37/67-kDa LR. Becerra and L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; identified as a PEDF one with potent phospholipase that We to on the membrane the LR. is a non-integrin laminin binding to PEDF (15Alberdi E. Hyde C.C. Becerra S.P. Biochemistry.. 1998; 37: 10643-10652Google Scholar, C. S. S. C. R. D. S. J... 2001; 20: Scholar). It is in the cell membrane and results from the of a known as receptor E. G. E. A. V. S. Mol. Biol. 1998; Scholar). an important role in cell and migration, angiogenesis, and tumor J. G. E. C. D. 2008; Scholar, E. B. L. M. C. E. S. Res... 2002; Scholar). and with the that the with PEDF the extracellular domain We to know the LR interact with PEDF in the and PEDF the of a 37/67-kDa LR-interacting on PEDF interact with in the This to protein membrane the of the domain in the LR. We performed in the yeast the and using and results that the two the the membrane of protein expression with a in the yeast the of we a using These results suggest that a the protein from LR. This the of interaction between LR with PEDF. of protein to protein the To identify the LR-interacting domain on PEDF, we PEDF from and and to of the We with (aa to of results a PEDF in N-terminal (aa 44–77) that interacts with This domain is also known as an the peptide S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar). of PEDF-interacting on different from the extracellular domain of the LR and to of These with the PEDF PEDF peptide (aa 44–77) as We that the PEDF-interacting domain on restricted to fragment and the interaction between PEDF and because the interaction in with the and to an interaction between LR and the PEDF the interaction with PEDF to Indeed, and with PEDF 34-mer, fragment peptide to the peptide (aa known to interact with laminin and protein C. S. S. C. R. D. S. J... 2001; 20: Scholar). Although peptide is to PEDF it the interaction between LR and PEDF and peptide. This that with other LR PEDF PEDF and LR in LR interact with PEDF in the we cells with PEDF and LR using a to interaction between the LR and PEDF in We PEDF and LR expression with and in and and as and We the of and on in the cells of the results also that and with a at the cell This interaction of PEDF and LR at the membrane of To the PEDF and LR we performed a We LR proteins, in E. with PEDF from we to the protein using as a that PEDF with LR 2 and a interaction between PEDF and LR. with to LR and PEDF. This to the fact that a that with the PEDF binding on LR. To we performed a His tag using LR and LR extracellular domain We that PEDF with the binding LR We further confirmed interaction surface plasmon resonance shows PEDF binding to LR and on the shows that the signals PEDF binding to LR and is to to PEDF to the surface in the of LR 25-mer PEDF to Cell research has that PEDF binds to at least two cell membrane receptors, one 80-kDa receptor and one 60-kDa receptor (21Alberdi E. Aymerich M.S. Becerra S.P. J. Biol. Chem... 1999; 274: 31605-31612Google Scholar, 22Bilak M.M. Becerra S.P. Vincent A.M. Moss B.H. Aymerich M.S. Kuncl R.W. J. Neurosci... 2002; 22: 9378-9386Google Scholar, 23Aymerich M.S. Alberdi E.M. Martínez A. Becerra S.P. Investig. Ophthalmol. Vis. Sci... 2001; 42: 3287-3293Google Scholar-24Yamagishi S. Inagaki Y. Nakamura K. R. T. A. Imaizumi T. J. Mol. Cell 2004; 37: Scholar). 80-kDa receptor the L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; Scholar). We that the 60-kDa receptor LR. the interaction between PEDF and LR and identified a PEDF we the biological of to the peptide exhibits S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar), and we a fragment elicit the effects. we used protein to the (aa 44–77) to and a 25-mer (aa as with a A and This peptide is on the surface of the of PEDF We used assays to the interaction between P46 and LR Our results show that P46 interacts with LR in an shows that the binding and that the to to with the P46 to the surface in the of LR We that peptide LR on cell membranes. We P46 peptide with at and a Our show binding to membrane binding cells also inhibits (13Selleri C. Ragno P. Ricci P. Visconte V. Scarpato N. Carriero M.V. Rotoli B. Rossi G. Montuori N. Blood.. 2006; 108: 2476-2484Google Scholar). also we used that with LR P46 at the and These results a 25-mer P46 the as know that PEDF has properties in and in (3Bouck N. Trends Mol. Med... 2002; 8: 330-334Google Scholar, 4Tombran-Tink J. Barnstable C.J. Nat. Rev. Neurosci... 2003; 4: 628-636Google Scholar, 5Becerra S.P. Exp. Eye Res... 2006; 82: 739-740Google E.T. Dass C.R. Choong P.F. Trends Mol. Med... 2006; 12: 497-502Google Scholar, S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar). We performed a angiogenesis in in to peptide P46 also has properties. cells tube-like on using a and Our results show that P46 inhibits tube-like network formation in the as PEDF whereas peptide has We the effects of the peptide on angiogenesis in ex vivo, results show that P46 inhibits angiogenesis as as PEDF PEDF, P46 Cell and assays like PEDF, P46 cell A and It is that PEDF has a on ECs R. S. T. J. Exp. Med... 2004; Scholar). We P46 inhibits formation We apoptosis assays and assays in the of and the with and growth the of cells about We between PEDF, and P46 to the and the of cells to in the and in the P46 and PEDF, cells in P46 cells and in PEDF. To further activation on protein from cells and with PEDF and P46 We the PEDF and P46 and activation LR expression inhibition. This the between PEDF and the in apoptosis and apoptosis PEDF and P46 We with LR we cells with PEDF P46 We using and We a LR protein expression in LR We the expression and a in LR protein in the LR cells with the and show the with in the cells with LR and of with PEDF P46 at the in the cells with the cells in the of PEDF We the is important in as but it is also in as D. J. 1996; Scholar, W. P. 2005; Scholar). to angiogenesis has a in PEDF, a inhibits angiogenesis in and in in N. Trends Mol. Med... 2002; 8: 330-334Google Scholar, 4Tombran-Tink J. Barnstable C.J. Nat. Rev. Neurosci... 2003; 4: 628-636Google Scholar, 5Becerra S.P. Exp. Eye Res... 2006; 82: 739-740Google E.T. Dass C.R. Choong P.F. Trends Mol. Med... 2006; 12: 497-502Google Scholar). Our results a evidence that PEDF receptors in the of different cell types, distinct receptors to elicit divergent least two receptors one of in ECs and another of in neuronal cells (21Alberdi E. Aymerich M.S. Becerra S.P. J. Biol. Chem... 1999; 274: 31605-31612Google Scholar, 22Bilak M.M. Becerra S.P. Vincent A.M. Moss B.H. Aymerich M.S. Kuncl R.W. J. Neurosci... 2002; 22: 9378-9386Google Scholar, 23Aymerich M.S. Alberdi E.M. Martínez A. Becerra S.P. Investig. Ophthalmol. Vis. Sci... 2001; 42: 3287-3293Google Scholar-24Yamagishi S. Inagaki Y. Nakamura K. R. T. A. Imaizumi T. J. Mol. Cell 2004; 37: Scholar). Recently, has identified as a PEDF receptor L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; Scholar). its phospholipase the 80-kDa receptor identified in neuronal PEDF its and in and receptor L. V. N. R. C. Notario S. J. J. Becerra S.P. J. Biol. Chem... 2006; Scholar, C. C. M. P. Crawford S.E. J. 2008; Scholar). We identified a PEDF the LR. This to the 60-kDa receptor in ECs S. Inagaki Y. Nakamura K. R. T. A. Imaizumi T. J. Mol. Cell 2004; 37: Scholar). It has that the laminin receptor of two laminin receptor and that the S. E. E. A. C. V. S. J. Cell Biochem... 1998; Scholar). between and we identified LR as a PEDF receptor the first We that PEDF interacts with the extracellular of but with in as His tag and that PEDF interact with This in results to a domain in LR protein membrane shows that PEDF and 25-mer PEDF peptide with LR on the interaction of PEDF with LR 2 and We further identified a 25-mer derived from PEDF, as a interaction 25-mer interact with to cell EC EC migration, and angiogenesis in and ex vivo, like PEDF to the of PEDF, as EC the T. Zhou W. M. Bouck Nat. Med... 2002; 8: Scholar). PEDF inhibits in R. R. J. Investig. Ophthalmol. Vis. Sci... 2003; Scholar), that other that PEDF interactions to retinal other that and EC apoptosis R. S. T. J. Exp. Med... 2004; Scholar, L. Barnstable C.J. Tombran-Tink J. Biochem. Biophys. Res. Commun... 2006; Scholar). J. M. J. Biol. Chem... 2006; that PEDF inhibits angiogenesis in bovine retinal ECs of the of inhibits We that LR in endothelial cells the Our that the of PEDF is at least binding LR. is binding the that inhibits to the effects of with to other used PEDF to and apoptosis in is in V. B. R. Res... 2004; Scholar), H. U. K. J... 2: Scholar), neuronal L. Proc. Natl. Acad. Sci. U. S. A... Scholar), epithelial M. J. Cell Scholar), and endothelial D. P. J. J. 1998; Indeed, PEDF and in many biological as P. Crawford S.E. H. Bouck 1999; Scholar, P. B. J. Biophys. Scholar), E.T. Dass C.R. Choong P.F. J. Res... Scholar, G. R. L.A. Res... Scholar), and J. Mol. Cell Biol. Res. Commun... in many cell PEDF, is also in retinal neuronal and vascular S. C. J. Exp. Eye Res... 2001; Scholar, E.M. J. Mol. Vis... 2002; 8: D. P. B. J. J. 2002; Scholar). ECs express at high retinal and protein expression show a expression at of retinal vascular with vascular and with vascular expression is S. C. J. Exp. Eye Res... 2001; Scholar). expression with the biological of expression of to the tumor angiogenesis of lung M. K. M. M. Y. T. Y. T. K. Scholar). we used to identify a PEDF (aa as S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; that interacts with of the extracellular the peptide (aa known to interact with laminin L. Proc. Natl. Acad. Sci. U. S. A... Scholar). peptide interact with PEDF in the N-terminal (aa the (aa but interaction with PEDF we peptide from peptide mediates of S. Volz K. T. Y. H. Aymerich M.S. Becerra S.P. R. D. Res... 2005; Scholar). Our is that a 25-mer a mediates PEDF binding to LR and and that like PEDF, inhibits angiogenesis in and ex This peptide to angiogenesis cell and as and activation studies tumor interfering with other PEDF effects. PEDF growth, it an tumor angiogenesis (3Bouck N. Trends Mol. Med... 2002; 8: 330-334Google Scholar, 4Tombran-Tink J. Barnstable C.J. Nat. Rev. Neurosci... 2003; 4: 628-636Google Scholar, 5Becerra S.P. Exp. Eye Res... 2006; 82: 739-740Google E.T. Dass C.R. Choong P.F. Trends Mol. Med... 2006; 12: 497-502Google Scholar, Y. Y. Y. K. Nakamura Y. T. 2005; Scholar). the 25-mer has a role in and Cell interaction with the laminin of is important cell LR as a receptor laminin but also binds S. J. Scholar, C. J. 2004; B. D. K. H. J. 2006; and the protein J. J. C. and S. J. Scholar). binds binds interaction C. S. S. C. R. D. S. J... 2001; 20: Scholar). 25-mer PEDF-interacting domain of peptide between residues a domain laminin and binding V. G. J. Cell Biochem... 1991; Scholar). 25-mer peptide to endothelial cells in the of an known to binding to its receptor. It to 25-mer peptide with interactions and to its properties. we LR is a PEDF receptor; the LR-interacting on PEDF is restricted to a 25-mer P46 the PEDF-interacting domain on LR is between and the and of and 25-mer binds to EC inhibits angiogenesis in and ex apoptosis and cell These results a the activities of PEDF. LR an as We D. M. A. C. and and M. K. with angiogenesis and S. the of peptide and with with

References

60